Decibel Cannabis (DB) Stock Price, News & Analysis

Company Overview

Decibel Cannabis Company Inc., an integrated cannabis company, engages in the cannabis cultivation, processing, and sale of cannabis flower products in Canada. It is also involved in the extraction, processing, and manufacturing vape cartridges, cannabis infused products, cannabis extracts, and glass tube packaging for pre-rolls. In addition, the company engages in the cannabis retail business through operating operational retail locations in Saskatchewan, as well as an e-commerce cannabis platform throughout the Province of Saskatchewan; and operational retail locations in Alberta. It offers its products under the Qwest, Vox, Blendcraft, and General Admission brands. Further, the company exports its products to Israel and Australia. Decibel Cannabis Company Inc. is headquartered in Calgary, Canada.

Key Stats

• Today's Range: C$0.13 to C$0.13
• 50-Day Range: C$0.08 to C$0.14
• 52-Week Range: C$0.04 to C$0.14
• Volume: 55,600 shs
• Average Volume: 278,660 shs
• Market Capitalization: C$74.99 million
• P/E Ratio: 4.33
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

DB Stock Analysis - Frequently Asked Questions

How have DB shares performed this year?

Decibel Cannabis' stock was trading at C$0.07 on January 1st, 2025. Since then, DB stock has increased by 85.7% and is now trading at C$0.13.

How do I buy shares of Decibel Cannabis?

Shares of DB stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

What other stocks do shareholders of Decibel Cannabis own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Decibel Cannabis investors own include AutoZone (AZO), Intel (INTC), CSLM Acquisition (SPWR), TJX Companies (TJX), Abacus Health Products (ABAHF), Avino Silver & Gold Mines (ASM) and Bank of America (BAC).

Industry, Sector and Symbol

• Stock Exchange: CVE
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: Banking
• Current Symbol: CVE:DB
• CIK: N/A
• Web: www.decibelcc.com
• Phone: 587-664-0300
• Fax: N/A
• Employees: 83,000
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): C$0.03
• Trailing P/E Ratio: 4.33
• Forward P/E Ratio: 13.00
• P/E Growth: N/A
• Net Income: -C$1.03 million
• Net Margins: -3.78%
• Pretax Margin: N/A
• Return on Equity: -1.05%
• Return on Assets: 3.04%

Debt

• Debt-to-Equity Ratio: 107.39
• Current Ratio: 1.27
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: C$100.50 million
• Price / Sales: 0.75
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: C$0.10 per share
• Price / Book: 1.30

Miscellaneous

• Outstanding Shares: 576,861,000
• Free Float: N/A
• Market Cap: C$74.99 million
• Optionable: N/A
• Beta: 1.08